about
Lipidomics reveals a remarkable diversity of lipids in human plasmaDeletion of the β-acetoacetyl synthase FabY in Pseudomonas aeruginosa induces hypoacylation of lipopolysaccharide and increases antimicrobial susceptibilitySubcellular Chemical Imaging of Antibiotics in Single Bacteria Using C60-Secondary Ion Mass Spectrometry.Discovery of new biosynthetic pathways: the lipid A story.Salmonella synthesizing 1-dephosphorylated [corrected] lipopolysaccharide exhibits low endotoxic activity while retaining its immunogenicity.Phosphate groups of lipid A are essential for Salmonella enterica serovar Typhimurium virulence and affect innate and adaptive immunityPathogenicity of Yersinia pestis synthesis of 1-dephosphorylated lipid A.Purification and mutagenesis of LpxL, the lauroyltransferase of Escherichia coli lipid A biosynthesis.Characterization of an Acinetobacter baumannii lptD Deletion Strain: Permeability Defects and Response to Inhibition of Lipopolysaccharide and Fatty Acid Biosynthesis.Differential inhibition of group IVA and group VIA phospholipases A2 by 2-oxoamides.Inhibition of group IVA cytosolic phospholipase A2 by novel 2-oxoamides in vitro, in cells, and in vivo.Uridine-based inhibitors as new leads for antibiotics targeting Escherichia coli LpxC.Purification and characterization of the lipid A 1-phosphatase LpxE of Rhizobium leguminosarum.Essential Ca(2+)-independent role of the group IVA cytosolic phospholipase A(2) C2 domain for interfacial activity.Novel 2-oxoamide inhibitors of human group IVA phospholipase A(2).In vivo phospholipase activity of the Pseudomonas aeruginosa cytotoxin ExoU and protection of mammalian cells with phospholipase A2 inhibitors.Synthesis and activity of 2-oxoamides containing long chain beta-amino acids.Structure-activity relationship of 2-oxoamide inhibition of group IVA cytosolic phospholipase A2 and group V secreted phospholipase A2.Molecular characterization and verification of azido-3,8-dideoxy-d-manno-oct-2-ulosonic acid incorporation into bacterial lipopolysaccharide.Palmitoylation State Impacts Induction of Innate and Acquired Immunity by the Salmonella enterica Serovar Typhimurium msbB Mutant.Density gradient enrichment of Escherichia coli lpxL mutants.A pathway-directed positive growth restoration assay to facilitate the discovery of lipid A and fatty acid biosynthesis inhibitors in Acinetobacter baumannii.Molecular Probes for the Determination of Subcellular Compound Exposure Profiles in Gram-Negative BacteriaMetabolic phospholipid labeling of intact bacteria enables a fluorescence assay that detects compromised outer membranesThe sialic acid transporter NanT is necessary and sufficient for uptake of 3-deoxy-d-manno-oct-2-ulosonic acid (Kdo) and its azido analog in Escherichia coliDevelopment and Optimization of a Higher-Throughput Bacterial Compound Accumulation AssayDefects in Efflux (oprM), β-Lactamase (ampC), and Lipopolysaccharide Transport (lptE) Genes Mediate Antibiotic Hypersusceptibility of Pseudomonas aeruginosa Strain Z61VNRX-5133 (Taniborbactam), a Broad-Spectrum Inhibitor of Serine- and Metallo-β-Lactamases, Restores Activity of Cefepime in Enterobacterales and Pseudomonas aeruginosa
P50
Q24633282-F879E1B6-D978-481F-94E4-7AC9843B4B04Q28493176-5F241AE9-E44B-47DF-A185-238BC60066DFQ33635077-92890A00-C738-4AFA-A27B-68CC3D797E99Q34599513-A1678332-67EA-4794-9F4F-06A44AAA45FDQ35059006-63594565-7D24-4E27-B185-207CAE2D0547Q36163168-9CF0D483-F96A-4F62-A906-5F0D1B0EE50DQ36804699-9CA3F1D5-B12E-415C-BB2F-8075273CF26EQ37147016-13DC482E-F213-49B2-A212-2B3435CF3118Q38386624-0BE7F752-EBCF-46E0-A704-4939328A0087Q40287484-1F999D68-AEB1-41F0-B224-B7CC3F1D9FCBQ40542143-422DA901-39EE-403F-8D0E-17D8BBB178E8Q43094957-1C8F0857-3B87-4164-849C-DDC2904211CCQ43217963-3466D6E7-1919-43FC-9567-9D7A0F2C6553Q43797881-9445169B-091C-4FA9-B50D-5944C83F8ECCQ44042842-F095BFC7-FDD6-4071-952E-AC1BDCFE9390Q44547313-67FF9123-CB3E-47D8-953A-15E8912A3FA0Q45213987-328665D1-12C2-4951-BB68-DF92E4E47B35Q46093638-B06E18C4-550D-45C1-AC28-0D2C41A4A7A1Q46406220-316D0376-887B-44DF-BB63-E87880992FA1Q46852120-74672DCA-EDA0-45D6-9833-74B0930CFB52Q47814437-0294620C-701D-462A-B532-AEBD07DED958Q52689133-3527BAF6-E87A-4C3B-9F79-C47F41AF5DE4Q88915163-7323C321-D599-4DDC-9C91-36B83B49D17BQ90198956-E3D82C0F-7037-4678-AC84-7EB9F4206A7CQ90750407-A2978E80-6411-4404-9990-8464AC894103Q90958082-9FB1B20E-E17A-4AD9-8026-2B795FC2E78CQ91623029-01B059A4-5323-49C3-AB4E-FC62E6014490Q92216886-673DE085-937E-465C-AD71-723649F9EC10
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
David A Six
@ast
David A Six
@en
David A Six
@es
David A Six
@nl
type
label
David A Six
@ast
David A Six
@en
David A Six
@es
David A Six
@nl
prefLabel
David A Six
@ast
David A Six
@en
David A Six
@es
David A Six
@nl
P106
P21
P31
P496
0000-0002-9013-1711